Kessler Topaz Meltzer & Check, LLP Files Class Action Lawsuit On Behalf of Chronic Hepatitis C Patients Against UnitedHealthCare
Kessler Topaz Meltzer & Check, LLP has filed a class action lawsuit against UnitedHealth Group Inc., UnitedHealthCare, Inc., UnitedHealthcare Life Insurance Co., Optum, Inc. and OptumRx, Inc. (collectively “Defendants”) for their allegedly unlawful denial of coverage and refusal to pay for Harvoni – a medically necessary treatment which can effectively cure chronic Hepatitis C (“CHC”).
About Hepatitis C and Harvoni
Hepatitis C is a widespread contagious disease that can lead to severe liver damage, cancer, and even death. In October 2014, the United States Food and Drug Administration (“FDA”) approved Harvoni, a prescription drug that can effectively cure Hepatitis C.
Harvoni is the first drug approved for the treatment of CHC that does not require combination with other drugs, and can effectively cure CHC in the vast majority of those affected.
Alleged Unlawful Conduct
Notwithstanding the life-saving treatment offered to CHC patients by Harvoni, Defendants have unlawfully limited Plaintiff’s and class members’ access to this “miracle drug” by developing arbitrary coverage criteria.
As detailed in the complaint Plaintiff and class members were diagnosed with Hepatitis C, prescribed Harvoni by their physicians, and unlawfully denied coverage of Harvoni by the Defendants. As a result, Plaintiff and class members have been and continue to be irreparably damaged by Defendants’ denial of coverage for their medically necessary Harvoni treatment.
If you or someone you know was denied Harvoni treatment by UnitedHealthCare, and would like to learn more about our investigation, please fill out our online form, or contact us today at 888-299-7706 or by email at firstname.lastname@example.org.